3 distinct disorders, paediatric/postviral origin, different mechanisms: NEONATAL HEPATITIS(morphologic pattern), BILIARY ATRESIA(developmental abnormality), REYE’S SYNDROME(postviral encephalopathy+fatty change).
= giant cell hepatitis/neonatal hepatocellular cholestasis. Morphologic change in conjugated hyperbilirubinaemia — known causes OR IDIOPATHIC(75%, MAJORITY). Not all cases truly inflammatory despite “hepatitis” name. Presents FIRST WEEK: jaundice, bilirubinuria, pale stools, ↑ALP.
Morphology (similar regardless of cause):
Intrauterine developmental abnormality — though “congenital,” actually mostly a PERINATAL INFLAMMATORY process destroying ducts (not primary formation defect). Range: complete absence(ATRESIA) to reduced number(PAUCITY). Extrahepatic vs intrahepatic.
Extrahepatic — ducts fail to develop/undergo perinatal sclerosis. Often multiple defects. Incidence 1/10,000 livebirths. Cholestatic jaundice within 1st week: severe pruritus, pale stools, dark urine, ↑transaminases. Surgically correctable in SOME; most need KASAI PROCEDURE(hepatic portoenterostomy) or transplant. Death: infection, liver failure, vitamin K deficiency bleeding/variceal bleeding. Cirrhosis+ascites=late(within 2yrs).
Morphology: Gross=enlarged, dark green, atretic ducts=cord-like. Micro (must distinguish from idiopathic neonatal hepatitis — ONLY atresia is surgically treatable — AND from α1-AT deficiency, similar biopsy appearance):
Intrahepatic — biliary HYPOPLASIA(paucity, not absence). Probable viral origin(intrauterine/neonatal). Cholestatic jaundice within days: ↑bile acids+pruritus, hypercholesterolaemia+xanthomas by 1yr. ↑hepatic+urinary copper. Some linked to α1-AT deficiency.
Morphology: paucity of intrahepatic ducts, cholestasis, ↑hepatic copper, portal inflammation/fibrosis→cirrhosis.
ACUTE POSTVIRAL syndrome: encephalopathy + VISCERAL FATTY CHANGE. Follows almost any virus, MC=influenza A/B, varicella. Viral effect often modified by SALICYLATES(key preventable trigger), aflatoxins, insecticides → mitochondrial injury+↓mitochondrial enzymes→↑blood ammonia+hepatocyte triglyceride accumulation.
Children 6mo-15yrs. Within 1wk of viral illness: intractable vomiting+progressive neuro deterioration→stupor→coma→death. Labs: ↑ammonia, ↑transaminases, ↑bilirubin, ↑PT.
Morphology: Gross=enlarged, yellowish-orange liver. Micro: MICROVESICULAR fat droplets in hepatocytes (contrast: alcoholic fatty liver=MACROVESICULAR — key discriminator, cross-ref Cirrhosis of the Liver). Similar fatty change in renal tubules, skeletal muscle, heart. Brain: oedema, ±focal neuronal necrosis.
Appears >3mg/dl, usually UNCONJUGATED. Hereditary non-haemolytic hyperbilirubinaemias: GILBERT’S(commonest, excellent prognosis), Crigler-Najjar(type1/2), DUBIN-JOHNSON(excellent prognosis).
Extrahepatic atresia vs idiopathic neonatal hepatitis = MOST urgent distinction — ONLY atresia is surgically correctable(Kasai) — timely biopsy determines whether baby gets life-saving surgery in the treatable window. Salicylate exposure during viral illness = classic PREVENTABLE Reye’s trigger — direct basis for avoiding aspirin in febrile children. Microvesicular(Reye’s) vs macrovesicular(alcoholic) fat = genuinely useful histologic discriminator. Extrahepatic atresia overlaps morphologically with BOTH idiopathic neonatal hepatitis AND α1-AT deficiency (cross-ref Hereditary and Metabolic Liver Diseases) — biopsy interpretation in jaundiced neonate must weigh all three together.
3 distinct disorders, paediatric/postviral origin, different mechanisms: NEONATAL HEPATITIS(morphologic pattern), BILIARY ATRESIA(developmental abnormality), REYE’S SYNDROME(postviral encephalopathy+fatty change).
= giant cell hepatitis/neonatal hepatocellular cholestasis. Morphologic change in conjugated hyperbilirubinaemia — known causes OR IDIOPATHIC(75%, MAJORITY). Not all cases truly inflammatory despite “hepatitis” name. Presents FIRST WEEK: jaundice, bilirubinuria, pale stools, ↑ALP.
Morphology (similar regardless of cause):
Intrauterine developmental abnormality — though “congenital,” actually mostly a PERINATAL INFLAMMATORY process destroying ducts (not primary formation defect). Range: complete absence(ATRESIA) to reduced number(PAUCITY). Extrahepatic vs intrahepatic.
Extrahepatic — ducts fail to develop/undergo perinatal sclerosis. Often multiple defects. Incidence 1/10,000 livebirths. Cholestatic jaundice within 1st week: severe pruritus, pale stools, dark urine, ↑transaminases. Surgically correctable in SOME; most need KASAI PROCEDURE(hepatic portoenterostomy) or transplant. Death: infection, liver failure, vitamin K deficiency bleeding/variceal bleeding. Cirrhosis+ascites=late(within 2yrs).
Morphology: Gross=enlarged, dark green, atretic ducts=cord-like. Micro (must distinguish from idiopathic neonatal hepatitis — ONLY atresia is surgically treatable — AND from α1-AT deficiency, similar biopsy appearance):
Intrahepatic — biliary HYPOPLASIA(paucity, not absence). Probable viral origin(intrauterine/neonatal). Cholestatic jaundice within days: ↑bile acids+pruritus, hypercholesterolaemia+xanthomas by 1yr. ↑hepatic+urinary copper. Some linked to α1-AT deficiency.
Morphology: paucity of intrahepatic ducts, cholestasis, ↑hepatic copper, portal inflammation/fibrosis→cirrhosis.
ACUTE POSTVIRAL syndrome: encephalopathy + VISCERAL FATTY CHANGE. Follows almost any virus, MC=influenza A/B, varicella. Viral effect often modified by SALICYLATES(key preventable trigger), aflatoxins, insecticides → mitochondrial injury+↓mitochondrial enzymes→↑blood ammonia+hepatocyte triglyceride accumulation.
Children 6mo-15yrs. Within 1wk of viral illness: intractable vomiting+progressive neuro deterioration→stupor→coma→death. Labs: ↑ammonia, ↑transaminases, ↑bilirubin, ↑PT.
Morphology: Gross=enlarged, yellowish-orange liver. Micro: MICROVESICULAR fat droplets in hepatocytes (contrast: alcoholic fatty liver=MACROVESICULAR — key discriminator, cross-ref Cirrhosis of the Liver). Similar fatty change in renal tubules, skeletal muscle, heart. Brain: oedema, ±focal neuronal necrosis.
Appears >3mg/dl, usually UNCONJUGATED. Hereditary non-haemolytic hyperbilirubinaemias: GILBERT’S(commonest, excellent prognosis), Crigler-Najjar(type1/2), DUBIN-JOHNSON(excellent prognosis).
Extrahepatic atresia vs idiopathic neonatal hepatitis = MOST urgent distinction — ONLY atresia is surgically correctable(Kasai) — timely biopsy determines whether baby gets life-saving surgery in the treatable window. Salicylate exposure during viral illness = classic PREVENTABLE Reye’s trigger — direct basis for avoiding aspirin in febrile children. Microvesicular(Reye’s) vs macrovesicular(alcoholic) fat = genuinely useful histologic discriminator. Extrahepatic atresia overlaps morphologically with BOTH idiopathic neonatal hepatitis AND α1-AT deficiency (cross-ref Hereditary and Metabolic Liver Diseases) — biopsy interpretation in jaundiced neonate must weigh all three together.
Three distinct disorders share a paediatric/postviral origin but differ sharply in mechanism: neonatal hepatitis (a morphologic pattern of conjugated hyperbilirubinaemia in infants), biliary atresia (intrauterine developmental abnormality of the biliary system), and Reye’s syndrome (an acute postviral encephalopathy with hepatic fatty change).
Also called giant cell hepatitis or neonatal hepatocellular cholestasis — a general term for the constant morphologic change seen in conjugated hyperbilirubinaemia from known infectious/metabolic causes, or of idiopathic etiology (idiopathic accounts for 75% of cases, the majority). Despite the shared grouping, not all cases are actually inflammatory, so the “hepatitis” name is somewhat misleading. Presents in the first week of life with jaundice, bilirubinuria, pale stools, high serum alkaline phosphatase.
Morphology (similar regardless of etiology):
Intrauterine developmental abnormalities of the biliary system — though classified as congenital, the abnormal development in most cases is actually a perinatal inflammatory process destroying the bile ducts (rather than a primary formation defect). Severity ranges from complete bile duct absence (atresia) to reduced bile duct numbers (paucity). Classified as extrahepatic or intrahepatic by the affected biliary segment.
Extrahepatic ducts fail to develop normally — absent at birth in some cases, or formed but undergoing perinatal sclerosis in others; multiple defects and other congenital lesions commonly coexist. Incidence: 1 per 10,000 livebirths. Cholestatic jaundice appears within the first week — severe pruritus, pale stools, dark urine, elevated transaminases. Some cases are surgically correctable; most are not, requiring hepatic portoenterostomy (Kasai procedure) or transplantation. Death from intercurrent infection, liver failure, or bleeding (vitamin K deficiency or oesophageal varices). Cirrhosis and ascites are late complications appearing within 2 years of age.
Morphology: Gross — enlarged, dark green liver; atretic biliary segments reduced to cord-like structures. Micro — must be distinguished from idiopathic neonatal hepatitis (surgery helps only in atresia, not idiopathic neonatal hepatitis) and from α1-antitrypsin deficiency (which produces a similar biopsy appearance):
Biliary hypoplasia — paucity rather than complete absence of bile ducts. Probable origin: viral infection acquired intrauterine or in the neonatal period. Cholestatic jaundice within the first few days — high serum bile acids with pruritus, hypercholesterolaemia with xanthomas by the first year. Elevated hepatic and urinary copper. Some cases relate to α1-antitrypsin deficiency.
Morphology: paucity of intrahepatic bile ducts; cholestasis; increased hepatic copper; portal inflammation/fibrosis eventually leading to cirrhosis.
An acute postviral syndrome of encephalopathy and fatty change in the viscera. May follow almost any viral illness, but most commonly influenza A/B and varicella. Viral infection may act alone, but its effect is often modified by exogenous factors — particularly salicylate administration, also aflatoxins and insecticides — which cause mitochondrial injury and reduced mitochondrial enzyme activity in the liver, leading to raised blood ammonia and hepatocyte triglyceride accumulation.
Affects children 6 months – 15 years. Within a week of a viral illness: intractable vomiting and progressive neurologic deterioration (encephalopathy) → stupor → coma → death. Labs: elevated blood ammonia, serum transaminases, bilirubin, prolonged PT.
Morphology: Gross — enlarged, yellowish-orange liver. Micro — hepatocytes show small microvesicular neutral fat droplets; similar fatty change in renal tubular epithelium, skeletal muscle, and heart cells; brain shows oedema and sometimes focal neuronal necrosis.
Neonatal jaundice appears at serum bilirubin >3 mg/dl, more often unconjugated. Hereditary non-haemolytic hyperbilirubinaemias (familial bilirubin metabolism disorders) include: Gilbert’s syndrome (commonest, excellent prognosis), Crigler-Najjar syndrome (types 1 and 2), and Dubin-Johnson syndrome (also excellent prognosis).
Three distinct disorders share a paediatric/postviral origin but differ sharply in mechanism: neonatal hepatitis (a morphologic pattern of conjugated hyperbilirubinaemia in infants), biliary atresia (intrauterine developmental abnormality of the biliary system), and Reye’s syndrome (an acute postviral encephalopathy with hepatic fatty change).
Also called giant cell hepatitis or neonatal hepatocellular cholestasis — a general term for the constant morphologic change seen in conjugated hyperbilirubinaemia from known infectious/metabolic causes, or of idiopathic etiology (idiopathic accounts for 75% of cases, the majority). Despite the shared grouping, not all cases are actually inflammatory, so the “hepatitis” name is somewhat misleading. Presents in the first week of life with jaundice, bilirubinuria, pale stools, high serum alkaline phosphatase.
Morphology (similar regardless of etiology):
Intrauterine developmental abnormalities of the biliary system — though classified as congenital, the abnormal development in most cases is actually a perinatal inflammatory process destroying the bile ducts (rather than a primary formation defect). Severity ranges from complete bile duct absence (atresia) to reduced bile duct numbers (paucity). Classified as extrahepatic or intrahepatic by the affected biliary segment.
Extrahepatic ducts fail to develop normally — absent at birth in some cases, or formed but undergoing perinatal sclerosis in others; multiple defects and other congenital lesions commonly coexist. Incidence: 1 per 10,000 livebirths. Cholestatic jaundice appears within the first week — severe pruritus, pale stools, dark urine, elevated transaminases. Some cases are surgically correctable; most are not, requiring hepatic portoenterostomy (Kasai procedure) or transplantation. Death from intercurrent infection, liver failure, or bleeding (vitamin K deficiency or oesophageal varices). Cirrhosis and ascites are late complications appearing within 2 years of age.
Morphology: Gross — enlarged, dark green liver; atretic biliary segments reduced to cord-like structures. Micro — must be distinguished from idiopathic neonatal hepatitis (surgery helps only in atresia, not idiopathic neonatal hepatitis) and from α1-antitrypsin deficiency (which produces a similar biopsy appearance):
Biliary hypoplasia — paucity rather than complete absence of bile ducts. Probable origin: viral infection acquired intrauterine or in the neonatal period. Cholestatic jaundice within the first few days — high serum bile acids with pruritus, hypercholesterolaemia with xanthomas by the first year. Elevated hepatic and urinary copper. Some cases relate to α1-antitrypsin deficiency.
Morphology: paucity of intrahepatic bile ducts; cholestasis; increased hepatic copper; portal inflammation/fibrosis eventually leading to cirrhosis.
An acute postviral syndrome of encephalopathy and fatty change in the viscera. May follow almost any viral illness, but most commonly influenza A/B and varicella. Viral infection may act alone, but its effect is often modified by exogenous factors — particularly salicylate administration, also aflatoxins and insecticides — which cause mitochondrial injury and reduced mitochondrial enzyme activity in the liver, leading to raised blood ammonia and hepatocyte triglyceride accumulation.
Affects children 6 months – 15 years. Within a week of a viral illness: intractable vomiting and progressive neurologic deterioration (encephalopathy) → stupor → coma → death. Labs: elevated blood ammonia, serum transaminases, bilirubin, prolonged PT.
Morphology: Gross — enlarged, yellowish-orange liver. Micro — hepatocytes show small microvesicular neutral fat droplets; similar fatty change in renal tubular epithelium, skeletal muscle, and heart cells; brain shows oedema and sometimes focal neuronal necrosis.
Neonatal jaundice appears at serum bilirubin >3 mg/dl, more often unconjugated. Hereditary non-haemolytic hyperbilirubinaemias (familial bilirubin metabolism disorders) include: Gilbert’s syndrome (commonest, excellent prognosis), Crigler-Najjar syndrome (types 1 and 2), and Dubin-Johnson syndrome (also excellent prognosis).
Personal revision notes, mnemonics and reminders.
